Pfizer, Moderna jabs reduce COVID-19 infection risk by 90% after second dose: US study

  • The study adds to evidence that new vaccines made with messenger RNA technology actually reduce the spread of the virus in real-world conditions
  • Participants were tested for Covid weekly and surveyed for reports of symptoms

Bloomberg
Updated29 Mar 2021, 09:06 PM IST
Photo: AFP
Photo: AFP

Covid-19 vaccines from Pfizer Inc. and Moderna Inc. effectively prevented coronavirus infections, not just illness, with substantial protection evident two weeks after the first dose, government researchers said.

Two doses of the vaccines provide as much as 90% protection against infection, according to data from U.S. Centers for Disease Control and Prevention study published Monday. Earlier clinical trials had established that the shots also prevent illness, hospitalizations, and deaths.

The study adds to evidence that new vaccines made with messenger RNA technology actually reduce the spread of the virus in real-world conditions. An earlier study in Israel found a single dose of the Pfizer vaccine reduced infections by as much as 85%.

The CDC studied a group of about 4,000 front-line workers, including health-care personnel, first responders, teachers and service workers from mid-December to mid-March as vaccines rolled out widely. These groups were among the first to be vaccinated, along with the vulnerable elderly, because of their risk of exposure to the virus.

Participants were tested for Covid weekly and surveyed for reports of symptoms. The researchers compared the frequency of Covid infections before and after vaccinations to estimate how effective the shots were at preventing SARS-CoV-2 spread, regardless of whether people felt sick or not.

Both the vaccines from Pfizer and partner BioNTech SE and Moderna require two doses spaced weeks apart. Two weeks after the first dose, the shots appeared to prevent 80% of infections; that rose to 90% two weeks after the second dose, when people were considered fully immunized.

Are mRNA Covid Vaccines Risky? What the Experts Say: QuickTake

The study included a mix of participants who were tested after developing symptoms as well as infections that were picked up by weekly tests when people were still feeling well. The results didn’t break out in detail the vaccine’s ability to prevent asymptomatic or minimally symptomatic infections.

“The study demonstrates that these two mRNA vaccines can reduce the risk of all SARS-CoV-2 infections, not just symptomatic infections,” the CDC said in a statement.

Estimates of how well the shots prevent infection should be interpreted cautiously, due to a relatively small number of infections confirmed, the CDC said. The agency also didn’t have enough data in this study to distinguish between the two vaccines. The study took place before a third vaccine from Johnson & Johnson became widely available.

For more articles like this, please visit us at bloomberg.com

©2021 Bloomberg L.P.

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:29 Mar 2021, 09:06 PM IST
Business NewsNewsWorldPfizer, Moderna jabs reduce COVID-19 infection risk by 90% after second dose: US study

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    NTPC share price

    392.45
    03:59 PM | 11 NOV 2024
    -5.25 (-1.32%)

    Tata Motors share price

    804.75
    03:59 PM | 11 NOV 2024
    -0.95 (-0.12%)

    ICICI Bank share price

    1,269.15
    03:58 PM | 11 NOV 2024
    9.8 (0.78%)

    Tata Steel share price

    144.95
    03:42 PM | 11 NOV 2024
    -2.6 (-1.76%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Wipro share price

    572.25
    03:59 PM | 11 NOV 2024
    3.4 (0.6%)

    Federal Bank share price

    207.75
    03:51 PM | 11 NOV 2024
    1 (0.48%)

    Indian Hotels Company share price

    729.45
    03:59 PM | 11 NOV 2024
    -3.6 (-0.49%)

    Page Industries share price

    47,349.95
    03:29 PM | 11 NOV 2024
    -637.85 (-1.33%)
    More from 52 Week High

    Asian Paints share price

    2,542.65
    03:44 PM | 11 NOV 2024
    -226.6 (-8.18%)

    CE Info Systems share price

    1,890.15
    03:53 PM | 11 NOV 2024
    -165.65 (-8.06%)

    UPL share price

    515.10
    03:47 PM | 11 NOV 2024
    -42.5 (-7.62%)

    Aarti Industries share price

    439.55
    03:58 PM | 11 NOV 2024
    -35.2 (-7.41%)
    More from Top Losers

    Biocon share price

    348.85
    03:58 PM | 11 NOV 2024
    27.6 (8.59%)

    Borosil Renewables share price

    503.10
    03:40 PM | 11 NOV 2024
    37.5 (8.05%)

    ITI share price

    327.40
    03:59 PM | 11 NOV 2024
    23.8 (7.84%)

    Power Finance Corp share price

    481.60
    03:58 PM | 11 NOV 2024
    32.15 (7.15%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      78,775.00-600.00
      Chennai
      78,781.00-600.00
      Delhi
      78,933.00-600.00
      Kolkata
      78,785.00-600.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L0.00
      Chennai
      100.80/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in News

        HomeMarketsPremiumInstant LoanMint Shorts